Key result
Conduction system pacing and CRT serve as key strategies to prevent and treat pacing-induced cardiomyopathy.
Why the study?
Pacing-induced cardiomyopathy is a complication of prolonged right ventricular pacing lacking a precise definition. This review aimed to analyze and systematize available data on pacing-induced cardiomyopathy, identify significant early predictors, and define evidence-based approaches for prevention and treatment.
Answers are grounded in this paper and cite their sources.
This review highlights that while cardiac resynchronization therapy is the primary treatment for pacing-induced cardiomyopathy, cardiac conduction system stimulation is emerging as both a preventative and therapeutic strategy.
Right ventricular apex lead position is the standard location for pacing. Electrical and mechanical dyssynchrony, resulting in abnormal ventricular contraction, leads to left ventricular myocardial remodeling, which in turn causes heart failure (HF) symptoms, increased HF-related hospitalization rate, atrial arrhythmias, and increased cardiovascular mortality. Pacing-induced cardiomyopathy (PICM) is a complication of prolonged right ventricular pacing. There is no precise definition of PICM, but it is generally defined as a decrease in left ventricular ejection fraction <50% or by ≥10% from baseline. The primary treatment option for PICM is cardiac resynchronization therapy. However, recent data indicate that cardiac conduction system stimulation may be not only a treatment but also a preventative measure for PICM. The aim of this review is to analyze and systematize the available data on PICM, identify the most significant early predictors, and define evidence-based approaches to improving prevention and treatment strategies.
No takes yet. Share an insight, caveat, or question.
Протасова et al. (2026) conducted a review in Pacing-induced cardiomyopathy (PICM). Cardiac resynchronization therapy or cardiac conduction system stimulation vs. Right ventricular apex pacing was evaluated on Prevention and treatment of pacing-induced cardiomyopathy (defined as LVEF <50% or decrease by ≥10% from baseline). Cardiac conduction system stimulation and cardiac resynchronization therapy are key strategies to prevent and treat pacing-induced cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: